Soluble endostatin is a novel inhibitor of epithelial repair in idiopathic pulmonary fibrosis
| Data(s) |
01/02/2009
|
|---|---|
| Resumo |
Background and aim: Aberrant angiogenesis and defective epithelial repair are key features of idiopathic pulmonary fibrosis (IPF). Endostatin is an antiangiogenic peptide with known effects on endothelial cells. This study aimed to establish the levels of endostatin in the bronchoalveolar lavage fluid (BALF) in IPF and to investigate its actions on distal lung epithelial cells (DLEC) and primary type II cells. |
| Identificador |
http://dx.doi.org/10.1136/thx.2008.102814 http://www.scopus.com/inward/record.url?scp=60549105237&partnerID=8YFLogxK |
| Idioma(s) |
eng |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
Richter , A G , McKeown , S , Rathinam , S , Harper , L , Rajesh , P , McAuley , D , Heljasvaara , R & Thickett , D R 2009 , ' Soluble endostatin is a novel inhibitor of epithelial repair in idiopathic pulmonary fibrosis ' Thorax , vol 64 , no. 2 , pp. 156-161 . DOI: 10.1136/thx.2008.102814 |
| Palavras-Chave | #/dk/atira/pure/subjectarea/asjc/2700/2740 #Pulmonary and Respiratory Medicine |
| Tipo |
article |
